Rituxan and Provigil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rituxan (rituximab) and Provigil (modafinil). Common drug interactions include constipation among females and memory impairment among males.

The phase IV clinical study analyzes what interactions people have when they take Rituxan and Provigil. It is created by eHealthMe based on reports of 72 people who take the same drugs from the FDA, and is updated regularly.

What is Rituxan?

Rituxan has active ingredients of rituximab. It is often used in rheumatoid arthritis. eHealthMe is studying from 64,791 Rituxan users. Check the latest studies of Rituxan.

What is Provigil?

Provigil has active ingredients of modafinil. It is often used in narcolepsy. eHealthMe is studying from 25,230 Provigil users. Check the latest studies of Provigil.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 28, 2026

72 people who take Rituxan and Provigil together, and have interactions are studied.

Rituxan and Provigil drug interactions.

What are the common drug interactions of Rituxan and Provigil, by gender? *:

female:

  1. Constipation
  2. Depression
  3. Fall
  4. Fibromyalgia (a long-term condition which causes pain all over the body)
  5. Genital herpes (herpes infection of genital)
  6. Glioblastoma (most common and most aggressive malignant primary brain tumour in humans)
  7. Hypertension (high blood pressure)
  8. Hypoaesthesia (reduced sense of touch or sensation)
  9. Immune system disorder
  10. Inflammation

male:

  1. Memory impairment
  2. Non-hodgkin's lymphoma recurrent (reoccurrence malignant (cancer) cells form in the lymph system)
  3. Decreased appetite
  4. Diabetes mellitus inadequate control
  5. Disease recurrence
  6. Dyspnoea exertional (breathlessness or shortness of breath)
  7. Ear infection
  8. Fall
  9. Febrile neutropenia (fever with reduced white blood cells)
  10. Haemoglobin decreased

What are the common drug interactions of Rituxan and Provigil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Alopecia (absence of hair from areas of the body)
  2. Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
  3. Drug ineffective
  4. Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  5. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  6. Optic neuritis (optic nerve inflammation)
  7. Primary progressive multiple sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged)
  8. Progressive relapsing multiple sclerosis (chronic autoimmune disease of the central nervous system in which gradual destruction of myelin occurs in patches throughout the brain or spinal cord or both)
  9. Relapsing-remitting multiple sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged)
  10. Secondary progressive multiple sclerosis (a stage of ms which comes after relapsing remitting ms in many cases)

30-39:

  1. B-lymphocyte count decreased
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Conjunctivitis (pink eye)
  4. Fall
  5. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  6. Headache (pain in head)
  7. Herpes zoster
  8. Kidney infection
  9. Migraine (headache)
  10. Muscular weakness (muscle weakness)

40-49:

  1. Herpes zoster
  2. Dizziness
  3. Balance disorder
  4. Blood folate decreased
  5. Breast cyst
  6. Chest discomfort
  7. Decreased appetite
  8. Discomfort
  9. Dyspnoea (difficult or laboured respiration)
  10. Dysstasia (difficulty in standing)

50-59:

  1. Culture urine positive
  2. Dehydration (dryness resulting from the removal of water)
  3. Gait disturbance
  4. Headache (pain in head)
  5. Hip arthroplasty
  6. Hypertension (high blood pressure)
  7. Influenza like illness
  8. Infusion related reaction
  9. Jc virus test positive
  10. Joint stiffness

60+:

  1. Interstitial lung disease
  2. Barrett's oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach)
  3. Adverse drug reaction
  4. Depression
  5. Fall
  6. Febrile neutropenia (fever with reduced white blood cells)
  7. Gait disturbance
  8. Genital herpes (herpes infection of genital)
  9. Glioblastoma (most common and most aggressive malignant primary brain tumour in humans)
  10. Hypoaesthesia (reduced sense of touch or sensation)

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 23 people, 31.94%
  2. Fatigue (feeling of tiredness): 8 people, 11.11%
  3. Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 6 people, 8.33%
  4. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 5 people, 6.94%
  5. Muscle Spasms (muscle contraction): 5 people, 6.94%
  6. Gait Disturbance: 5 people, 6.94%
  7. Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 4 people, 5.56%
  8. Nausea (feeling of having an urge to vomit): 4 people, 5.56%
  9. Immunodeficiency Common Variable: 4 people, 5.56%
  10. Hypersensitivity: 4 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Rituxan and Provigil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rituxan and Provigil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rituxan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Provigil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rituxan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Provigil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on rituximab and modafinil (the active ingredients of Rituxan and Provigil, respectively), and Rituxan and Provigil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: